Evidence map›Paper›PMID 30997352›Full record

ArticleJournal of translational internal medicine2019

Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C.

Amal Ahmed Mohamed, Eman R Abd Almonaem, Amira I Mansour, HebatAllah Fadel Algebaly, Rania Abdelmonem Khattab, Yasmine S El Abd

Open access · hybridAbstract read
In one paragraph

Article in Journal of translational internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amal Ahmed MohamedBiochemistry and Molecular Biology, Biochemistry Department, National Hepatology and Tropical Centre, Cairo, Egypt.
Eman R Abd AlmonaemDepartment of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt.
Amira I MansourDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Benha, Egypt.
HebatAllah Fadel AlgebalyDepartment of Pediatrics, Pediatric and Pediatric Intensive Care, Cairo University School of Medicine, Cairo, Egypt.
Rania Abdelmonem KhattabDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Yasmine S El AbdDepartment of Microbial Biotechnology, Genetic Engineering and Biotechnology Division, National Research Centre, Cairo, Egypt.
Benha University · EGCairo University · EGNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveHepcidin is the key regulator of iron metabolism and is a significant biomarker for systemic inflammatory states. Vitamin D is a powerful immunomodulator and plays a significant role in the inflammatory responses and fibrosis occurring due to hepatitis C virus (HCV) infection. This study assessed the level of vitamin D and serum hepcidin and its expression in peripheral blood of children with chronic hepatitis C (CHC) and correlated them with other serum markers to reflect iron metabolism and liver disease severity.

methodsA total of 100 children were included in this study: 50 with HCV infection and 50 healthy controls. Biochemical parameters together with vitamin D, hepcidin, and its expression were all measured.

resultsThe level of hepcidin and its expression together with vitamin D and hepcidin-to-ferritin (H/F) ratios were significantly reduced in patients, but the iron and ferritin levels were higher (

conclusionMeasuring serum hepcidin and its expression together with vitamin D levels in patients may have a prognostic value and is promising in the follow-up of the severity of liver disease.

Indexed as

hepatitis Chepcidinhepcidin-to-ferritin ratiovitamin D

Identifiers

PMID30997352
PMCPMC6463826
OpenAlexW2936105754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.